Jill Kolesar
University of Kentucky
H-index: 48
North America-United States
Top articles of Jill Kolesar
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract B020: M1 macrophage engineered vesicles as ovarian cancer treatment in a mouse xenograft model | Cancer Research | Connie D Cao Joseph R McCorkle Namrata Anand Donglin Yan David Schweer | 2024/3/4 |
Abstract PO3-03-01: Impact of Environmental Temperature on Clinical Outcomes and Tumor Microenvironment of Early-Stage Breast Cancer | Cancer Research | Arya Mariam Roy Spencer Rosario Anthony George Qiang Hu Brian Czerniecki | 2024/5/2 |
Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study | JCO Precision Oncology | Megan L Hutchcraft Shulin Zhang Nan Lin Justine C Pickarski Elizabeth A Belcher | 2024/1 |
Abstract B021: A phase 1 dose escalation study of lapatinib and paclitaxel in recurrent ovarian cancer | Cancer Research | Connie D Cao Joseph R McCorkle Donglin Yan Rani Jayswal Rachel W Miller | 2024/3/4 |
CHEK2 Founder Variants and Thyroid Cancer Risk | Thyroid | Pamela Brock Sandya Liynarachchi Taina T Nieminen Carlos Chan Wendy Kohlmann | 2024/2/27 |
Non-melanoma skin cancer event rates in a formalized clinical trial setting: considerations for clinical trial design | European Journal of Cancer Prevention | Taja Lozar Kyungmann Kim Thomas C Havighurst Gary S Wood Jill M Kolesar | 2024/1/1 |
ASO Visual Abstract: Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using the Codman Vascular Catheter with the … | Annals of surgical oncology | Hannah G McDonald Omar A Zaki Matt J Wright Rani Jayswal Heidi Weiss | 2024/2 |
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer | Cancers | J Robert McCorkle Rebecca Ahn Connie D Cao Kristen S Hill Charles S Dietrich | 2024/3/28 |
Phase II trial of ArtemiCoffee for men with biochemical recurrence of prostate cancer after local therapy. | Zin Myint William H St. Clair Stephen Strup Patrick J Hensley Donglin Yan | 2024/2/1 | |
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG … | Journal of Clinical Oncology | Leonard J Appleman Se Eun Kim Wayne B Harris Sumanta K Pal Michael R Pins | 2024/3/26 |
Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump … | Annals of Surgical Oncology | Hannah G McDonald Omar A Zaki Matt J Wright Rani Jayswal Heidi Weiss | 2024/2 |
Inhibition of FASN postpones development of resistance to BRAF inhibitors in colorectal cancer | Cancer Research | Mariah Geisen Josiane weber-Tessmann Courtney Kelson Daheng He Chi Wang | 2024/3/22 |
Sex-based differences in the transcriptomic metabolic profiling in young onset colorectal cancer (YOCRC). | Deepak Vadehra Spencer Rosario Jianmin Wang Yali Zhang Emily Isenhart | 2024/1/20 | |
Increased Incidence of DACH1 Mutation in Appalachian Women with Uterine Cancer and Altered Chemotherapy Sensitivity | McKayla Riggs Nan Lin Kristen Hill Guogen Mao Breanna Knicely | 2023/6/9 | |
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer | Nathan D Seligson Jill M Kolesar Benish Alam Laura Baker Jatinder K Lamba | 2023/8 | |
Impact of Environmental Temperature on Clinical Outcomes and Tumor Microenvironment of Early-Stage Breast Cancer | International Journal of Cancer Care and Delivery | Arya M Roy Spencer Rosario Anthony George Qiang Hu Brian Czerniecki | 2023/12/7 |
ETCTN 10450: A phase I trial of peposertib and lutetium 177 DOTATATE in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). | Aman Chauhan Jill Kolesar Donglin Yan Daneng Li Aman Khurana | 2023/2/1 | |
Pan-cancer landscape of programmed death ligand-1 and programmed death ligand-2 structural variations | JCO precision oncology | Emily L Hoskins Eric Samorodnitsky Michele R Wing Julie W Reeser Julia F Hopkins | 2023/1 |
Targeting lipid metabolism to improve efficacy of braf-targeted therapy in colorectal cancer | Cancer Research | Mariah E Geisen Dang he Chi Wang Jill M Kolesar Yekaterina Zaytseva | 2023/4/4 |
Windows of Opportunities: Orientation, Sizing and PV-Shading of the Glazed Area to Reduce Cooling Energy Demand in Sub-Sahara Africa | CANCERS | Zin WW Myint William HH St Clair Stephen EE Strup Donglin Yan Ning Li | 2023/4/27 |
Co-Authors
